Know Cancer

or
forgot password

Dynamic Area Telethermometry (DAT) as an Auxiliary Imaging Modality in Assessment of Patients With Cancer


N/A
16 Years
N/A
Not Enrolling
Both
Malignant Tumors, Subcutaneous Tumors, Lymph Node Tumors

Thank you

Trial Information

Dynamic Area Telethermometry (DAT) as an Auxiliary Imaging Modality in Assessment of Patients With Cancer


- The DAT system resembles a video camera which picks up changes in body temperature
which may reflect disease-related changes in blood flow to some areas, particularly
those involved with tumors.

- Patients with known tumor sites amendable to DAT evaluation will be imaged at the time
of staging and at later time points. Thermal profiles will be compared to those of
normal adjacent tissues and correlated with the images of the tumors on conventional
images.


Inclusion Criteria:



- Histologically confirmed malignancy

- Primary or secondary tumor location amendable to DAT scanning: subcutaneous tissues

- Older than 15 years of age

- Able to withhold movement for 20 seconds, hold breath for 20 seconds for chest wall
lesions and clinically stable acutely

Exclusion Criteria:

- Uncontrolled motion

- Tumors not verified or measurable by standard imaging

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To assess the feasibility of DAT in tumors detected by conventional imaging and evaluation of therapy induced changes in DAT imaging profile over time.

Principal Investigator

Milos Janicek, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dana-Farber Cancer Institute

Authority:

United States: Institutional Review Board

Study ID:

99-331

NCT ID:

NCT00165100

Start Date:

January 2000

Completion Date:

October 2002

Related Keywords:

  • Malignant Tumors
  • Subcutaneous Tumors
  • Lymph Node Tumors
  • DAT
  • imaging modality
  • Neoplasms

Name

Location

Dana-Farber Cancer Institute Boston, Massachusetts  02115